Australia is close to approving COVID-19 vaccinations for children aged between six months to five years after the Therapeutic Goods Administration (TGA) granted provisional determination to Pfizer.
This will be the first step to gaining registration on the Register of Therapeutic Goods for Pfizer, along with Moderna’s SpikeVax.
“Approval and potential supply in Australia would only commence should the vaccine be approved as safe and effective by the TGA and recommended for administration to this age group by the [Australian Technical Advisory Group on Immunisation],” according to a statement from the TGA.
“It does not mean an application for use in this age group has been made, and it does not mean any subsequent application would be approved.”
The body said it would carry out a “rigorous assessment” of the safety and efficacy of the vaccine.
Australia Adjusting to New COVID-Normal
The country is on track to record its 10,000th death from COVID-19, with the current death toll at 9,886.Health authorities are also concerned that the winter season could see Australians catch the virus a second time.
Dr. Kerry Chant, the chief health officer of New South Wales, said there was no evidence that new sub-variants of COVID-19 could lead to severe illness, but there was “evidence that they are better at evading the body’s immunity.”
“So it is vital that anyone who is eligible for a booster dose who hasn’t yet received it does so as soon as possible,” she said in comments obtained by AAP.
“As we move to the next stage of the pandemic, we will be adjusting our approach in relation to mandatory vaccinations,” according to Yvette D’Ath, the Queensland health minister, in a press release.
While the Northern Territory government will soon close its Howard Springs quarantine facility.
